You are here: Home > News > Latest updates & news > Coronavirus > Optometry Australia CPD offerings (update)
Read time:


By Optometry Australia

Optometry Australia is committed to ensuring that you have ready access to the education that you need to meet your CPD obligations given the COVID-19 constraints.

We have curated for you a range of online education offerings that you can access via our Institute of Excellence and that will help you meet your CPD requirements.

Comprehensive program of webcasts to come

In the following weeks, we will deliver an enhanced program of interesting subjects that you can participate in from the comfort of your home.

And do not forget Optometry Virtually Connected, your three-day virtual event will be held totally online from 26-28 June 2020.The program is being finalised and this, along with registration details, will be released to you in the next few weeks.

Independent Learning you can do now

Pre-recorded webcasts that are ready for viewing include:

Our latest Pharma issues are also available for you to access, all offering six points including therapeutic points:

  • In the March issue of Pharma, we take a deeper look at collaborative care, delving into clinical examples of how it can enhance the profession of optometry and produce better patient outcomes. This issue provides 6 (4T) CPD points. Complete the quiz and your CPD points will be automatically entered into your ‘MyCPD record.’
  • December 2019 issue of Pharma – 6 (4T) CPD points.
  • September 2019 issue of Pharma – 6 (1T) CPD points.
Filed in category: Coronavirus, CPD, conferences & events, General news, Member resources, National & State initiatives, Workplace
Tagged as: ,

Acknowledgement of Country

In the spirit of reconciliation Optometry Australia acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.